Lanzamiento Enero 2027

Ensayo controlado aleatorizado2026

Photobiomodulation therapy in the treatment of genitourinary syndrome in postmenopausal women - a placebo-controlled double-blind clinical trial

Pereira SRDS, Lanzafame R, Mesquita-Ferrari RA, Salviatto LTC, Melo EDS, Bezerra CDDS, Bossini PS, Almeida-Lopes L, Dalapria V, Deana AM

Climacteric : the journal of the International Menopause Society · 0 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Sin clasificar
NUPEN

Según 1 financiador declarado.

Publicación

Publicado
2026-04-30 · Climacteric · vol. 29 · número 4 · págs. 620–630
Editorial
Taylor & Francis
Citado
0 citas · más que el 32% de estudios similares · 0.0× el promedio de su campo
Referencias
21 trabajos
Acceso
De pago
Áreas de investigación
Laser Applications in Dentistry and Medicine · Pelvic floor disorders treatments · Urinary Bladder and Prostate Research
Palabras clave
low-level laser therapy, genitourinary syndrome of menopause, postmenopausal women, urinary incontinence, vaginal dryness, sexual function, pelvic pressure, estrogen deficiency, non-invasive treatment
MeSH
vagina, humans, urinary incontinence, syndrome, treatment outcome, double-blind method, postmenopause, aged, middle aged, female, female urogenital diseases, low-level light therapy

10 autores

  • Silvia Regina dos Santos Pereira🇧🇷Universidade Nove de Julho
  • Raymond J. Lanzafame🇺🇸The Society of Laparoscopic and Robotic Surgeons; University at Buffalo, State University of New York
  • Raquel Agnelli Mesquita‐Ferrari🇧🇷Universidade Nove de Julho
  • Luciana Toledo Costa Salviatto🇧🇷Universidade Nove de Julho
  • Erika da Silva Melo🇧🇷Universidade Nove de Julho
  • Cícero Dayves da Silva Bezerra🇧🇷Universidade Nove de Julho
  • Paulo Sérgio Bossini
  • Luciana Almeida-Lopes
  • Vanessa Dalapria🇧🇷Universidade Nove de Julho
  • Alessandro Melo Deana🇧🇷 · autor de correspondenciaUniversidade Nove de Julho

Resumen

El texto original del estudio, en el idioma en que se publicó.

Postmenopausal genitourinary syndrome of menopause (GSM) includes a range of genital, urinary and sexual symptoms caused by estrogen deficiency. As women spend about one-third of their lives postmenopause, effective, non-invasive treatments are needed. This study evaluated the clinical effects of photobiomodulation (PBM) therapy in postmenopausal women with urinary incontinence. A randomized, double-blind, placebo-controlled clinical trial was conducted with women over 50 years of age presenting one or more GSM symptoms. Participants were assigned to receive either PBM or placebo. The PBM group underwent four weekly sessions of 808 nm laser applied to eight vaginal points (4J per point, 40s each). The placebo group followed the same protocol with the device turned off. Results showed a significant reduction in urinary loss in the PBM group, with improved scores on the International Consultation on Incontinence Questionnaire - Short Form. While pelvic pressure and sexual function did not differ significantly, improvements in vaginal dryness and burning were reported. PBM appears to be a promising, non-invasive option for reducing urinary incontinence and enhancing aspects of vaginal health in postmenopausal women. Further studies are needed to confirm long-term effects and optimize treatment protocols.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.